JPMorgan Chase & Co’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.57M | Buy |
748,067
+405,612
| +118% | +$1.4M | ﹤0.01% | 3170 |
|
|
2025
Q1 | $729K | Buy |
342,455
+193,410
| +130% | +$412K | ﹤0.01% | 3826 |
|
|
2024
Q4 | $475K | Buy |
149,045
+124,133
| +498% | +$396K | ﹤0.01% | 4178 |
|
|
2024
Q3 | $333K | Buy |
24,912
+4,844
| +24% | +$64.7K | ﹤0.01% | 4235 |
|
|
2024
Q2 | $200K | Sell |
20,068
-238,045
| -92% | -$2.37M | ﹤0.01% | 4277 |
|
|
2024
Q1 | $3.07M | Buy |
258,113
+258,065
| +537,635% | +$3.07M | ﹤0.01% | 2868 |
|
|
2023
Q4 | $194 | Buy |
48
+15
| +45% | +$61 | ﹤0.01% | 6012 |
|
|
2023
Q3 | $90 | Buy |
+33
| New | +$90 | ﹤0.01% | 5960 |
|